Terms: = Kidney tumors AND NCOA4, RP11-481A12_4, 8031, ENSG00000138293, PTC3, ELE1, Q13772, RFG, DKFZp762E1112, ARA70 AND Clinical Outcome
286 results:
1. Spreading Through Air Spaces And Thinking About Lung Metastases.
M Castro P; Rei J; Silva C; Miranda J; Guerra M
Port J Card Thorac Vasc Surg; 2023 Oct; 30(3):31-35. PubMed ID: 38499034
[TBL] [Abstract] [Full Text] [Related]
2. Correlation of Cerebrospinal Fluid Total Protein and Serum Neutrophil-to-Lymphocyte Ratio with clinical outcomes of Guillain-Barre Syndrome Variants.
Bano S; Nawaz A; Nasim A; Numan A; Zahid M
J Coll Physicians Surg Pak; 2024 Feb; 34(2):187-192. PubMed ID: 38342870
[TBL] [Abstract] [Full Text] [Related]
3. Characteristics and clinical outcomes of Children With Wilms' Tumour: A 15-year Experience in a Single Centre in Nigeria.
Nasir AA; Abdur-Raheem NT; Abdur-Rahman LO; Ibiyeye TT; Sayomi TO; Adedoyin OT; Adeniran JO
J Pediatr Surg; 2024 May; 59(5):1009-1014. PubMed ID: 38184433
[TBL] [Abstract] [Full Text] [Related]
4. Papillary renal neoplasm with reverse polarity: a clinicopathologic study of 43 cases with a focus on the expression of KRAS signaling pathway downstream effectors.
Kim B; Lee S; Moon KC
Hum Pathol; 2023 Dec; 142():1-6. PubMed ID: 37797754
[TBL] [Abstract] [Full Text] [Related]
5. Predictive factors and prognosis of upper gastrointestinal bleeding in gastric cancer: A large population-based study (UGIB-GC trial).
Kiattiweerasak A; Bongkotvirawan P; Aumpan N; Yamaoka Y; Miftahussurur M; Vilaichone RK
PLoS One; 2023; 18(9):e0291926. PubMed ID: 37729185
[TBL] [Abstract] [Full Text] [Related]
6. [clinical outcome of Surgical Resection for Renal Cell Carcinoma with Inferior Vena Cava Tumor Thrombus].
Nakanishi H; Ohba K; Nakamura Y; Yasuda T; Mitsunari K; Matsuo T; Mochizuki Y; Miyata Y
Hinyokika Kiyo; 2023 Aug; 69(8):207-214. PubMed ID: 37667597
[TBL] [Abstract] [Full Text] [Related]
7. Vascular endothelial profilin-1 drives a protumorigenic tumor microenvironment and tumor progression in renal cancer.
Gau D; Daoud A; Allen A; Joy M; Sagan A; Lee S; Lucas PC; Duensing S; Boone D; Osmanbeyoglu HU; Roy P
J Biol Chem; 2023 Aug; 299(8):105044. PubMed ID: 37451478
[TBL] [Abstract] [Full Text] [Related]
8. Diagnostic Accuracy Of Contrast Enhanced Ct For Detection Of Renal Cell Carcinoma Taking Histopathology As Gold Standard.
Akram F; Mazhar A; Javed H; Fayyaz M; Khan A; Ahmad K
J Ayub Med Coll Abbottabad; 2023; 35(1):84-87. PubMed ID: 36849383
[TBL] [Abstract] [Full Text] [Related]
9. Order of patient entry and outcomes in phase II clinical trials: A meta-analysis of individual patient data.
Behrendt CE; Villalona-Calero MA; Newman EM; Frankel PH
Contemp Clin Trials; 2023 Feb; 125():107083. PubMed ID: 36638911
[TBL] [Abstract] [Full Text] [Related]
10. An Enhancer Demethylator Phenotype Converged to Immune Dysfunction and Resistance to Immune Checkpoint Inhibitors in Clear-Cell Renal Cell Carcinomas.
Lu X; Vano Y; Helleux A; Su X; Lindner V; Davidson G; Mouawad R; Spano JP; Rouprêt M; Elaidi R; Compérat E; Verkarre V; Sun C; Chevreau C; Bennamoun M; Lang H; Tricard T; Cheng W; Xu L; Davidson I; Yan F; Fridman WH; Sautes-Fridman C; Oudard S; Malouf GG
Clin Cancer Res; 2023 Apr; 29(7):1279-1291. PubMed ID: 36374555
[TBL] [Abstract] [Full Text] [Related]
11. Discovery of pathway-independent protein signatures associated with clinical outcome in human cancer cohorts.
Konaté MM; Li MC; McShane LM; Zhao Y
Sci Rep; 2022 Nov; 12(1):19283. PubMed ID: 36369472
[TBL] [Abstract] [Full Text] [Related]
12. Biphasic squamoid alveolar papillary renal cell carcinoma: A unique papillary renal cell carcinoma with distinctive morphology, immunophenotype and molecular genetic features.
Li Y; Wu X; Yang J; Jiang Y; Li Y; Zhang W; Yu W
Pathol Res Pract; 2022 Nov; 239():154120. PubMed ID: 36201928
[TBL] [Abstract] [Full Text] [Related]
13. Factors affecting prognosis of the patients with severe hyponatremia.
Turkmen E; Karatas A; Altindal M
Nefrologia (Engl Ed); 2022; 42(2):196-202. PubMed ID: 36153916
[TBL] [Abstract] [Full Text] [Related]
14. The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIs.
Del Re M; Crucitta S; Paolieri F; Cucchiara F; Verzoni E; Bloise F; Ciampi R; Mercinelli C; Capuano A; Sportiello L; Martinetti A; Procopio G; Galli L; Porta C; Bracarda S; Danesi R
J Transl Med; 2022 Aug; 20(1):371. PubMed ID: 35974365
[TBL] [Abstract] [Full Text] [Related]
15. [Real-world data analysis of 3012 patients undergoing laparoscopic radical gastrectomy in a single center over the past 12 years].
Wang LJ; Li Z; Wang S; Liu HD; Li QY; Li BW; Xu JH; Ge H; Wang WZ; Li FY; He ZY; Zhang DC; Xu H; Yang L; Xu ZK
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Aug; 25(8):716-725. PubMed ID: 35970806
[No Abstract] [Full Text] [Related]
16. Minors at risk of von Hippel-Lindau disease: 10 years' experience of predictive genetic testing and follow-up adherence.
Vibert R; Lahlou-Laforêt K; Samadi M; Krivosic V; Blanc T; Amar L; Burnichon N; Abadie C; Richard S; Gimenez-Roqueplo AP
Eur J Hum Genet; 2022 Oct; 30(10):1171-1177. PubMed ID: 35918537
[TBL] [Abstract] [Full Text] [Related]
17. Real-world efficacy and safety of nivolumab plus ipilimumab in untreated metastatic renal cell carcinoma, and the impact of previous nephrectomy on clinical outcome: Japanese multi-institutional retrospective study.
Kato T; Fujita K; Minami T; Nagahara A; Hyashi Y; Nakata W; Matsuzaki K; Nakano K; Hatano K; Kawashima A; Imamura R; Takada S; Nishimura K; Tsujihata M; Takao T; Nakai Y; Nakayama M; Nishimura K; Uemura M; Uemura H; Nonomura N
Int J Clin Oncol; 2022 Oct; 27(10):1596-1604. PubMed ID: 35831538
[TBL] [Abstract] [Full Text] [Related]
18. Histologic diversity in chromophobe renal cell carcinoma does not impact survival outcome: A comparative international multi-institutional study.
Kolar J; Llaurado AF; Ulamec M; Skenderi F; Perez-Montiel D; Alvarado-Cabrero I; Bulimbasic S; Sperga M; Tretiakova M; Osunkoya AO; Rogala J; Comperat E; Gal V; Dunatov A; Pivovarcikova K; Michalova K; Vesela AB; Slisarenko M; Strakova AP; Pitra T; Hora M; Michal M; Alaghehbandan R; Hes O
Ann Diagn Pathol; 2022 Oct; 60():151978. PubMed ID: 35609473
[TBL] [Abstract] [Full Text] [Related]
19. Clinicopathological and molecular characterization of biphasic hyalinizing psammomatous renal cell carcinoma: further support for the newly proposed entity.
Wang XT; Xia QY; Fang R; Zhang RS; Ye SB; Li R; Wang X; Lu ZF; Ma HH; Zhou XJ; He HY; Zhao M; Rao Q
Hum Pathol; 2022 May; 123():102-112. PubMed ID: 35192800
[TBL] [Abstract] [Full Text] [Related]
20. Association of sunitinib concentration and clinical outcome in patients with metastatic renal cell carcinoma treated with a 2-week-on and 1-week-off schedule.
Ito T; Yamamoto K; Furukawa J; Harada K; Fujisawa M; Omura T; Yano I
J Clin Pharm Ther; 2022 Jan; 47(1):81-88. PubMed ID: 34669974
[TBL] [Abstract] [Full Text] [Related]
[Next]
